Literature DB >> 27230064

Current management of the neck in salivary gland carcinomas.

Ben Green1, Siavash Rahimi2, Peter A Brennan3.   

Abstract

Salivary gland cancers include a diverse group of tumours with many histological subtypes which occur in both major and minor salivary glands. As a result of this heterogeneity and different sites of presentation, there have been no randomised controlled trials to evaluate the indications and efficacy of neck treatments by either surgery or radiotherapy for occult or apparent neck node metastases. Neck dissection is an important treatment strategy for neck metastases arising from major and minor salivary gland malignancy as well as being useful for disease staging. However, there is considerable controversy in how to manage the neck in these patients. In this review, we discuss the management of neck metastases relating to malignant salivary gland tumours.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  clinically negative neck, review; clinically positive neck; neck dissection; neck metastases; salivary gland carcinoma

Mesh:

Year:  2016        PMID: 27230064     DOI: 10.1111/jop.12458

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  2 in total

1.  Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel.

Authors:  Daniel N Johnson; Mine Onenerk; Jeffrey F Krane; Esther Diana Rossi; Zubair Baloch; Güliz Barkan; Massimo Bongiovanni; Fabiano Callegari; Sule Canberk; Glen Dixon; Andrew Field; Christopher C Griffith; Nirag Jhala; Sara Jiang; Daniel Kurtycz; Lester Layfield; Oscar Lin; Zahra Maleki; Miguel Perez-Machado; Marc Pusztaszeri; Philippe Vielh; He Wang; Matthew A Zarka; William C Faquin
Journal:  Cancer Cytopathol       Date:  2020-04-08       Impact factor: 5.284

2.  Management of clinically negative neck in salivary gland cancers - elective neck dissection, irradiation, or surveillance?

Authors:  Mateusz Szewczyk; Paweł Golusiński; Jakub Pazdrowski; Piotr Pieńkowski; Wojciech J Golusiński
Journal:  Contemp Oncol (Pozn)       Date:  2019-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.